If you have been reading about CJC-1295 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
The two variants differ dramatically in how long they persist in circulation. The form lacking the albumin-binding group has a plasma half-life measured in tens of minutes, comparable to the natural hormone fragment. The version carrying the drug affinity complex binds albumin and shows a half-life of roughly six to eight days in human studies. That figure comes from small trials that tracked hormone levels over extended periods. The physiological consequences of sustained versus pulsatile stimulation are still debated and the literature does not settle the point.
Lyophilized peptide powder is comparatively stable when kept dry, cold, and protected from light. Once dissolved, the molecule is vulnerable to deamidation, oxidation, and aggregation, with the rate depending on pH, buffer composition, and temperature. Alkaline conditions and repeated freeze-thaw cycles accelerate loss of the intact peptide. The methionine present in the native sequence is a known oxidation site, which is one reason it was replaced in the modified fragment. Suppliers typically recommend cold storage of solutions and use within a short window.
Reverse-phase high-performance liquid chromatography is the standard tool for purity assessment. The technique separates the target peptide from truncated or modified byproducts. Mass spectrometry confirms molecular weight and supports sequence verification. Electrospray ionization and matrix-assisted laser desorption are both used. Amino acid analysis provides an independent check on composition. Purity values are commonly reported as area percentage from the chromatogram. Residual trifluoroacetate and water content are also measured in many quality programs.
Batch-to-batch consistency depends on solid-phase peptide synthesis and subsequent purification. Coupling efficiency, resin choice, and cleavage conditions all affect the final profile. Counter-ion content and moisture can shift the apparent mass of a batch. Documentation typically includes a certificate of analysis with chromatograms and spectra. Independent verification by a second laboratory is sometimes requested. Whether a given certificate reflects the actual vial contents depends on chain of custody. Analytical methods themselves carry uncertainty that should be stated alongside results.
Lyophilized material is typically stored at minus twenty degrees Celsius or lower. Keeping the vial dry and protected from light preserves peptide integrity. Repeated freeze-thaw cycles can cause aggregation or loss of activity. Once dissolved, solutions are generally kept at two to eight degrees Celsius. Stability data for reconstituted solutions vary, and long-term behavior is not fully established. Working aliquots reduce the number of times a stock container is opened.
| Property | Value | Notes |
|---|---|---|
| Molecular mass | Approximately 3.4 to 3.6 kDa | Depends on whether the affinity complex is attached |
| Appearance | White to off-white lyophilized powder | Freeze-dried solid, often in a sealed vial |
| Solubility | Soluble in water and aqueous buffers | Dissolution rate varies with pH and buffer salt |
| Typical storage | Below minus 20 degrees Celsius, dry and dark | Dissolved material is usually kept cold and used promptly |
| Common analytical methods | Reversed-phase HPLC and mass spectrometry | Peptide mapping and amino acid analysis add sequence detail |
CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.
The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.
Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.
Two related peptides circulate under the CJC-1295 label, and they differ mainly in how long they persist in circulation. The version carrying a drug affinity complex includes a maleimidopropionic acid linker that forms a covalent bond with serum albumin. The other version, usually written as modified GRF(1-29) or tetrasubstituted GRF(1-29), lacks that linker and is cleared quickly. Mixing the two produces inconsistent readings of published half-life values, because the linker rather than the receptor-facing sequence drives most of the difference.
The core sequence keeps the receptor-binding region of GHRH while replacing four positions that are vulnerable to dipeptidyl peptidase-4 and other proteases. Substitutions at positions 2, 8, 15, and 27 raise metabolic stability relative to the natural hormone. The N-terminal residues remain essential for activity, so changes there generally lower potency. Molecular weight sits near 3368 daltons for the tetrasubstituted analog without the linker, while the albumin-binding form is heavier because of the added maleimide group.
CJC-1295 is a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. Its sequence corresponds to the first twenty-nine residues of human GHRH, with four substitutions that slow enzymatic breakdown. Early descriptions placed the compound in research on growth hormone deficiency and related conditions, and later literature groups it with the long-acting GHRH analogs. The name appears in both laboratory and popular fitness writing, where it sometimes labels chemically different peptides.
CJC-1295 is a synthetic peptide designed to mimic growth hormone-releasing hormone (GHRH), the endogenous signal that prompts the pituitary gland to release growth hormone. The compound is a modified fragment of the natural hormone, spanning the first twenty-nine amino acids of GHRH with several substitutions that slow enzymatic breakdown. Two variants circulate in research settings: one carrying a drug affinity complex (DAC) and one without it. The DAC-free form is frequently labelled Mod GRF(1-29) in catalogs and discussion forums.
The peptide binds GHRH receptors on somatotroph cells within the anterior pituitary, triggering a signalling cascade that increases growth hormone secretion. Its improved resistance to dipeptidyl peptidase IV degradation distinguishes it from the parent hormone. In the DAC-bearing version, a maleimide group reacts with a cysteine residue on serum albumin, forming a covalent bond that keeps the peptide in circulation far longer. That albumin attachment is the central design feature separating the two research variants.
Pharmacokinetic behaviour differs sharply between the two forms. The DAC-bearing peptide shows an extended circulation time measured in days, whereas the version without the complex is cleared within roughly half an hour. This gap shapes how researchers design dosing schedules in animal models. Whether the prolonged presence of the DAC form produces effects meaningfully different from the short-acting variant remains an open question, since comparative human data are scarce.
=== Excessive sweating === Botulinum toxin (BTO) injections are a modern clinical trend to treat hyperhidrosis, of which palmar hyperhidrosis is a frequent symptom. For example, AbobotulinumtoxinA has been approved for the treatment of axillary hyperhidrosis, which cannot be managed by topical agents.
=== Arms Offences Act === The Arms Offences Act regulates criminal offences dealing with firearms and weapons. Any person who uses or attempts to use arms (Section 4) can face execution, as well as any person who uses or attempts to use arms to commit scheduled offences (Section 4A). These scheduled offences are being a member of an unlawful assembly; rioting; certain offences against the person; abduction or kidnapping; extortion; burglary; robbery; preventing or resisting arrest; vandalism; mischief. Any person who is an accomplice (Section 5) to a person convicted of arms use during a scheduled offence can likewise be hanged. Trafficking in arms (Section 6) is a capital offence in Singapore. Under the Arms Offences Act, trafficking is defined as being in unlawful possession of more than two firearms. One notable case involving a conviction under this act was the murder of Lim Hock Soon, where Ang Soon Tong triad leader Tan Chor Jin used a Beretta pistol to fatally shoot Lim, a nightclub owner, to death after robbing him and his family of their valuables. Tan was initially charged under the Penal Code for murder but the charge was later amended into one of illegal discharge of firearms under the Arms Offences Act. Tan was eventually convicted and executed by hanging under this Act on 9 January 2009.
Mohs surgery can also be more cost-effective than other surgical methods, when considering the cost of surgical removal and separate histopathological analysis. However, Mohs surgery should be reserved for the treatment of skin cancers in anatomic areas where tissue preservation is of utmost importance (face, neck, hands, lower legs, feet, genitals).
==== Protein-based adhesives ==== Protein-based adhesives are less prevalent and typically used to consolidate painted textiles or multi-media objects, of which fabric is one component. They include isinglass, gelatin, and animal glues.
Sources: en.wikipedia.org
The predictions of the effects of a major countervalue nuclear exchange include millions of city dweller deaths within a short period of time. Some 1980s predictions had gone further and argued that a full-scale nuclear war could eventually bring about human extinction. Such predictions, sometimes but not always based on total war with nuclear arsenals at Cold War highs, received contemporary criticism. On the other hand, some 1980s governmental predictions, such as FEMA's CRP-2B and NATO's Carte Blanche, have received criticism from groups such as the Federation of American Scientists for being overly optimistic. CRP-2B, for instance, predicted that 80% of Americans would survive a nuclear exchange with the Soviet Union, a figure that neglected nuclear war's impacts on healthcare infrastructure, the food supply, and the ecosystem and assumed that all major cities could be successfully evacuated within 3–5 days. A number of Cold War publications advocated preparations that could purportedly enable a large proportion of civilians to survive even a total nuclear war. Among these is Nuclear War Survival Skills. To avoid injury and death from a nuclear weapon's heat flash and blast effects, the two most common causes of injury from nuclear weapons, schoolchildren were taught to duck and cover by the early Cold War film of the same name. Such advice is once again being given in case of nuclear terrorist attacks.
Kopeček, "Refolding Hydrogels Self-Assembled from N-(2-Hydroxypropyl)methacrylamide Graft Copolymers by Antiparallel Coiled-Coil Formation". Biomacromolecules 7, 1187–1195 (2006) J.-G. Shiah, Y. Sun, C.M. Peterson, R.C. Straight, J. Kopeček, "Antitumor Activity of N-(2-Hydroxypropyl)methacrylamide Copolymer-Meso Chlorin e6 and Adriamycin Conjugates in Combination Treatments". Clinical Cancer Research 6, 1008–1015 (2000) T. Minko, P. Kopečková, J. Kopeček, "Efficacy of Chemotherapeutic Action of HPMA Copolymer-Bound Doxorubicin in a Solid Tumor Model of Ovarian Carcinoma". International Journal of Cancer 86, 108–117 (2000) Z.-R. Lu, P. Kopečková, J. Kopeček, "Polymerizable Fab’ Antibody Fragments for Targeting of Anticancer Drugs". Nature Biotechnology 17, 1101–1104 (1999) C. Wang, R.J. Stewart, J. Kopeček, "Hybrid Hydrogels Assembled from Synthetic Polymers and Coiled-Coil Protein Domains". Nature 397, 417–420 (1999) N.L. Krinick, Y. Sun, D. Joyner, J.D. Spikes, R.C. Straight, J. Kopeček, "A Polymeric Drug Delivery System for the Simultaneous Delivery of Drugs Activatable by Enzymes and/or Light". Journal of Biomaterials Science, Polymer Edition 5, 303–324 (1994) R. Duncan, P. Kopečková, J. Strohalm, I.C. Hume, J.B. Lloyd, J. Kopeček, "Anticancer Agents Coupled to N-(2-Hydroxypropyl)methacrylamide Copolymers. 2. Evaluation of Daunomycin Conjugates In Vivo against L1210 Leukaemia". British Journal of Cancer 57, 147–156 (1988) P. Rejmanová, J. Pohl, M. Baudyš, V. Kostka, J. Kopeček, "Polymers Containing Enzymatically Degradable Bonds. 8.
Once the substrate is bound and oriented to the active site, catalysis can begin. The residues of the catalytic site are typically very close to the binding site, and some residues can have dual-roles in both binding and catalysis. Catalytic residues of the site interact with the substrate to lower the activation energy of a reaction and thereby make it proceed faster. They do this by a number of different mechanisms including the approximation of the reactants, nucleophilic/electrophilic catalysis and acid/base catalysis. These mechanisms will be explained below.
Sources: en.wikipedia.org
The version carrying the affinity complex bears a maleimide group that binds serum albumin, which extends its circulation time to several days. The version without it lacks this group and clears within roughly half an hour. The two are chemically related but behave very differently once in the body.
In common usage the name without the affinity complex is often equated with MOD GRF 1-29, a fragment carrying four stabilizing substitutions. Strictly speaking, the term originally referred to the albumin-binding version. The overlap in naming causes frequent ambiguity in both informal and technical writing.
Reversed-phase chromatography separates the peptide from related impurities and yields a purity estimate. Mass spectrometry confirms the molecular mass and detects modifications such as oxidation. Sequence-level checks rely on peptide mapping or amino acid analysis when stronger confirmation is needed.
The powder is normally held at minus twenty degrees Celsius or below. Light and moisture exposure should be minimized. Repeated warming and cooling cycles are avoided.